Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
2019 · Journal of Hematology & Oncology · 859 citations
https://doi.org/10.1186/s13045-019-0770-1
S
Siwei Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
3.9K
Citations
29
h-index
49
i10-index
Siwei Wang is an academic researcher from South China Agricultural University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & RNA modifications and cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 29, co-authored 133 publications.
ORCID: 0000-0001-5077-060XPapers by this author
worksHigh-performance ferroelectric field-effect transistors with ultra-thin indium tin oxide channels for flexible and transparent electronics
2024 · Nature Communications · 94 citations
https://doi.org/10.1038/s41467-024-46878-5
The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway
2020 · Oncogenesis · 46 citations
https://doi.org/10.1038/s41389-020-0217-0
MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma
2021 · Cell Death and Disease · 43 citations
https://doi.org/10.1038/s41419-021-03715-7
Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number
2017 · Radiation Oncology · 34 citations
https://doi.org/10.1186/s13014-017-0946-1
Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma
2020 · Nature Communications · 29 citations
https://doi.org/10.1038/s41467-020-19855-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat